Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alibaba Health Information Technology ( (HK:0241) ) has shared an announcement.
Alibaba Health Information Technology Limited has announced the grant of 949,000 Restricted Share Units (RSUs) to 17 employees as part of its 2024 Share Award Scheme. This initiative is designed to incentivize employees and align their interests with the company’s long-term goals, potentially enhancing employee retention and motivation. The RSUs have varied vesting periods, primarily between two to four years, and are subject to specific terms and conditions set by the company.
The most recent analyst rating on (HK:0241) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare industry, focusing on providing healthcare services and products. The company is known for its digital health services and initiatives aimed at enhancing healthcare accessibility and efficiency.
YTD Price Performance: 111.14%
Average Trading Volume: 153,397,491
Technical Sentiment Signal: Buy
Current Market Cap: HK$113B
For an in-depth examination of 0241 stock, go to TipRanks’ Overview page.